Gbm clinical trials

Explore recruiting gbm clinical trials.

Recruiting gbm studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gbm trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3 open-label, controlled, randomised, multi-centre trial comparing imlifidase and standard-of-care with standard-of-care alone in the treatment of severe anti-GBM antibody disease (Goodpasture disease)

Spain, Czechia, Germany, France, Italy, Sweden +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

GBM AGILE Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent Glioblastoma (GBM)

Germany, France

Phase II and Phase III (Integrated) EU CTIS Study details

A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent Glioblastoma Multiforme (WHO Grade IV) After Failure of Standard First Line Therapy

Spain, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1 Safety and Dose Finding Study of 131I -TLX101 Plus Standard of Care in Patients with Newly Diagnosed Glioblastoma

Austria, Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Phase 2, open-label, single-arm study on the use of metformin as adjunctive therapy in high-grade glioma

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Unravelling the invisiBle infiltRating cOmponeNT Of glioblaStomA Using mRi USpio (BRONTOSAURUS)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Gbm trials by city

Gbm in Toronto Gbm in Vancouver Gbm in Montreal Gbm in Calgary Gbm in Edmonton Gbm in Ottawa Gbm in Winnipeg Gbm in Quebec City Gbm in Hamilton Gbm in Kitchener Gbm in London Gbm in Halifax Gbm in New York Gbm in Los Angeles Gbm in Chicago Gbm in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease